SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
4.880
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
4.885
+0.005 (0.10%)
After-hours: Apr 28, 2026, 7:54 PM EDT
SLS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | - | 1 | 7.6 | |
| Revenue Growth (YoY) | - | - | - | -86.84% | 300.00% | |
| Cost of Revenue | - | - | - | 0.1 | 0.2 | |
| Gross Profit | - | - | - | 0.9 | 7.4 | |
| Selling, General & Admin | 11.15 | 12.42 | 13.86 | 12.58 | 11.32 | |
| Research & Development | 16.02 | 19.1 | 24.01 | 20.27 | 15.67 | |
| Operating Expenses | 27.17 | 31.51 | 37.87 | 32.85 | 26.99 | |
| Operating Income | -27.17 | -31.51 | -37.87 | -31.95 | -19.59 | |
| Interest & Investment Income | 1.41 | 0.63 | 0.53 | 0.32 | 0.01 | |
| Other Non Operating Income (Expenses) | - | - | 0 | 0.04 | 0.02 | |
| EBT Excluding Unusual Items | -25.76 | -30.88 | -37.34 | -31.6 | -19.57 | |
| Other Unusual Items | -1.1 | - | - | 0.3 | 4.34 | |
| Pretax Income | -26.86 | -30.88 | -37.34 | -41.3 | -20.94 | |
| Income Tax Expense | - | - | - | - | -0.24 | |
| Net Income | -26.86 | -30.88 | -37.34 | -41.3 | -20.7 | |
| Net Income to Common | -26.86 | -30.88 | -37.34 | -41.3 | -20.7 | |
| Shares Outstanding (Basic) | 109 | 61 | 28 | 19 | 15 | |
| Shares Outstanding (Diluted) | 109 | 61 | 28 | 19 | 15 | |
| Shares Change (YoY) | 78.18% | 120.33% | 43.21% | 25.29% | 94.07% | |
| EPS (Basic) | -0.25 | -0.50 | -1.34 | -2.13 | -1.34 | |
| EPS (Diluted) | -0.25 | -0.50 | -1.34 | -2.13 | -1.34 | |
| Free Cash Flow | -28.39 | -35.4 | -31.41 | -23.81 | -26.02 | |
| Free Cash Flow Per Share | -0.26 | -0.58 | -1.13 | -1.23 | -1.68 | |
| Gross Margin | - | - | - | 90.00% | 97.37% | |
| Operating Margin | - | - | - | -3195.00% | -257.82% | |
| Profit Margin | - | - | - | -4130.10% | -272.36% | |
| Free Cash Flow Margin | - | - | - | -2380.90% | -342.38% | |
| EBIT | -27.17 | -31.51 | -37.87 | -31.95 | -19.59 | |
| EBIT Margin | - | - | - | - | -257.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.